Agreement between FRAX scores calculated with and without bone mineral density in women with osteopenia in Turkey

Clinical Rheumatology

Volumn 33, Issue 12, 2014, Pages 1785-1789

  Olmez Sarikaya, Nese ^a   Kapar Yavasi, Secil ^a   Tan, Gulten ^a   Satiroglu, Servet ^a   Yildiz, Arife Hilal ^a   Oz, Bengi ^a   Yoleri, Ozlem ^a   Memis, Asuman ^a  

^a Izmir Ataturk Training and Research Hospital   (Turkey)

Author keywords

Bone mineral density; Dual energy X ray absorptiometry; FRAX; Osteoporosis

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASSESSMENT OF HUMANS; BONE DENSITY; CORRELATION COEFFICIENT; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; FRAX SCORE; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; OSTEOPENIA; POSTMENOPAUSE; PRIORITY JOURNAL; SCORING SYSTEM; TURKEY (REPUBLIC); ALGORITHM; DENSITOMETRY; FRAGILITY FRACTURE; METABOLIC BONE DISEASE; MIDDLE AGED; PATHOLOGY; PHOTON ABSORPTIOMETRY; POSTMENOPAUSE OSTEOPOROSIS; PROBABILITY; RADIOGRAPHY; TURKEY;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; ALGORITHMS; BONE DENSITY; BONE DISEASES, METABOLIC; CROSS-SECTIONAL STUDIES; DENSITOMETRY; FEMALE; FEMUR NECK; HIP FRACTURES; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPOROTIC FRACTURES; POSTMENOPAUSE; PROBABILITY; TURKEY;

EID: 84937965186     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-014-2491-8     Document Type: Article

References (22)

1. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19(4):385–397
2. Kanis JA, McCloskey E, Johansson H, Oden A, Leslie WD (2012) FRAX (®) with and without bone mineral density. Calcif Tissue Int 90(1):1–13
3. Johansson H, Kanis JA, Oden A, Johnell O, McCloskey E (2009) BMD, clinical risk factors and their combination for hip fracture prevention. Osteoporos Int 20:1675–1682
4. Leslie WD, Morin S, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA, for the Manitoba Bone Density Program (2012) Fracture risk assessment without bone density measurement in routine clinical practice. Osteoporos Int 23(1):75–85
5. Leslie WD, Majumdar SR, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA, Manitoba Bone Density Program (2012) High fracture probability with FRAX usually indicates densitometric osteoporosis: implications for clinical practice. Osteoporos Int 23(1):391–397
6. National Osteoporosis Foundation (2010) Clinician’s guide to prevention and treatment of osteoporosis. National Osteoporosis Foundation, Washington, DC
7. Kanis JA, Hans D, Cooper C, Baim S, Bilezikian JP, Binkley N, Cauley JA, Compston JE, Dawson-Hughes B, El-Hajj Fuleihan G, Johansson H, Leslie WD, Lewiecki EM, Luckey M, Oden A, Papapoulos SE, Poiana C, Rizzoli R, Wahl DA, McCloskey EV (2011) Task force of the FRAX initiative. Interpretation and use of FRAX in clinical practice. Osteoporos Int 22(9):2395–2411
8. Wainwright SA, Marshall LM, Ensrud KE, Cauley JA, Black DM, Hillier TA, Hochberg MC, Vogt MT, Orwoll ES; Study of Osteoporotic Fractures Research Group (2005) Hip fracture in women without osteoporosis. J Clin Endocrinol Metab 90(5):2787–2793
9. Kanis JA, Borgstrom F, De Laet C, Johansson H, Johnell O, Jonsson B, Oden A, Zethraeus N, Pfleger B, Khaltaev N (2005) Assessment of fracture risk. Osteoporos Int 16(6):581–589
10. Fleiss JL (1986) The design and analysis of clinical experiments. John Wiley & Sons Inc, New York, pp 1–32
11. Tuzun S, Eskiyurt N, Akarirmak U, Saridogan M, Johansson H, McCloskey E, Kanis JA (2012) Turkish osteoporosis society. The impact of a FRAX-based intervention threshold in Turkey: the FRAX-TURK study. Arch Osteoporos 7(1–2):229–235
12. Ilias I, Spanoudi F, Koukkou E, Nikopoulou SC (2012) Use of the FRAX calculator with and without bone mineral density in Greek women. Hormones (Athens) 11(2):222–223
13. Hamdy RC, Kiebzak GM (2009) Variance in 10-year fracture risk calculated with and without T-scores in select subgroups of normal and osteoporotic patients. J Clin Densitom 12(2):158–161
14. Gadam RK, Schlauch K, Izuora KE (2013) Frax prediction without BMD for assessment of osteoporotic fracture risk. Endocr Pract 19(5):780–784
15. Lewiecki EM, Bilezikian JP, Khosla S, Marcus R, McClung MR, Miller PD, Watts NB, Maricic M (2011) Osteoporosis update from the 2010 Santa Fe bone symposium. J Clin Densitom 14(1):1–21
16. Gómez-Vaquero C, Bianchi M, Santo P, Roig-Vilaseca D, Narváez J, Nolla JM (2012) The activity of a Spanish bone densitometry unit revisited under the point of view of FRAX. Reumatol Clin 8(4):179–183
17. Kanis JA, Johnell O, De Laet C, Jonsson B, Oden A, Oglesby A (2002) International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res 17:1237–1244
18. Assessment of osteoporosis at the primary health care level (2007) Report of a WHO scientific group. World Health Organization Collaborating Center for Metabolic Bone Diseases. Sheffield UK: University of Sheffield
19. Kanis JA (2008) on behalf of the World Health Organization Scientific Group Assessment of osteoporosis at the primary healthcare level. Technical Report. WHO Collaborating Centre, University of Sheffield, UK
20. Compston J, Bowring C, Cooper A, Cooper C, Davies C, Francis R, Kanis JA, Marsh D, McCloskey EV, Reid DM, Selby P (2013) Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update. Maturitas 75(4):392–396
21. Aubry-Rozier B, Stoll D, Krieg MA, Lamy O, Hans D (2013) What was your fracture risk evaluated by FRAX® the day before your osteoporotic fracture? Clin Rheumatol 32(2):219–223
22. Watts NB, Siris ES, Cummings SR, Bauer DC (2010) Filtering FRAX. Osteoporos Int 21(4):537–541